$12.3 Million is the total value of ALTEGRIS ADVISORS, L.L.C.'s 8 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 214.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LQD | New | ISHARES TRiboxx inv cp etf | $6,701,000 | – | 57,188 | +100.0% | 54.56% | – |
| XLP | New | SELECT SECTOR SPDR TRsbi cons stpls | $1,641,000 | – | 31,738 | +100.0% | 13.36% | – |
| HYG | New | ISHARES TRiboxx hi yd etf | $1,555,000 | – | 17,968 | +100.0% | 12.66% | – |
| XLI | New | SELECT SECTOR SPDR TRsbi int-inds | $771,000 | – | 12,385 | +100.0% | 6.28% | – |
| XLY | New | SELECT SECTOR SPDR TRsbi cons discr | $599,000 | – | 7,359 | +100.0% | 4.88% | – |
| XLB | New | SELECT SECTOR SPDR TRsbi materials | $442,000 | – | 8,899 | +100.0% | 3.60% | – |
| XLV | New | SELECT SECTOR SPDR TRsbi healthcare | $322,000 | – | 4,673 | +100.0% | 2.62% | – |
| TIP | New | ISHARES TRtips bd etf | $252,000 | – | 2,225 | +100.0% | 2.05% | – |
| DYNC | Exit | Dynegy Inc 7.000000 07/01/2019unit 07/01/20191 | $0 | – | -5,000 | -100.0% | -4.18% | – |
| Exit | Palo Alto Networks, Inc. 0% 7/1/2019note 7/0 | $0 | – | -500,000 | -100.0% | -7.86% | – | |
| Exit | AMTRUST FINANCIAL SERVIC 2.75% 12/15/2044note 2.750%12/1 | $0 | – | -1,000,000 | -100.0% | -8.90% | – | |
| Exit | salesforce.com, inc. 0.25% 4/1/2018note 0.250% 4/0 | $0 | – | -750,000 | -100.0% | -9.25% | – | |
| Exit | NXP SEMICONDUCTOR NVdbcv 1.000%12/0 | $0 | – | -1,000,000 | -100.0% | -12.15% | – | |
| AGNPRA | Exit | Allergan plc 5.500000 03/01/2018pfd conv ser a | $0 | – | -1,750 | -100.0% | -14.83% | – |
| Exit | QQQ US 11/18/16 P113put | $0 | – | -35,000 | -100.0% | -42.84% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- AqGen Liberty Management I, Inc. #1
- Altegris Holdings II, LLC #2
- AqGen Liberty Holdings, LLC #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QQQ US 11/18/16 P113 | 9 | Q3 2016 | 49.0% |
| ALBANY MOLECULAR RESH INC | 7 | Q2 2016 | 9.4% |
| INFINERA CORPORATION | 7 | Q2 2016 | 12.2% |
| VEREIT Inc Convertible 3% Due 8/1/2018 FA1 | 7 | Q3 2015 | 8.8% |
| Allergan Public Limited Company Preferred | 6 | Q3 2016 | 21.7% |
| VEREIT Inc Convertible 3 3/4% Due 12/15/2020 JD15 | 6 | Q3 2015 | 4.6% |
| Salesforce.com Inc Convertible 0 1/4% Due 4/1/2018 AO1 | 5 | Q3 2016 | 18.7% |
| Palo Alto Networks, Inc 144A Due 7/1/2019 At Mat | 5 | Q3 2016 | 11.1% |
| NXP SEMICONDUCTORS N V | 4 | Q3 2016 | 15.7% |
| PRICELINE GRP INC | 4 | Q4 2015 | 9.6% |
View ALTEGRIS ADVISORS, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-04-02 |
| 13F-NT | 2024-02-14 |
| 13F-NT | 2023-11-09 |
| 13F-NT | 2023-08-10 |
| 13F-NT | 2023-05-09 |
| 13F-NT | 2023-02-15 |
| 13F-NT | 2022-10-28 |
| 13F-NT | 2022-07-26 |
| 13F-NT | 2022-05-11 |
| 13F-NT | 2022-02-04 |
View ALTEGRIS ADVISORS, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.